Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.
All content for MODCAST is the property of March of Dimes and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.
Dr. Sam Mesiano on the Enzyme Discovery that Could Revive Progesterone Therapy for Preterm Birth
MODCAST
1 hour 17 minutes
1 year ago
Dr. Sam Mesiano on the Enzyme Discovery that Could Revive Progesterone Therapy for Preterm Birth
Dr. Sam Mesiano, an investigator at the March of Dimes Ohio Collaborative Prematurity Research Center, discusses the enzyme that leads to progesterone withdrawal and labor in cases of infection-related preterm birth - and how this enzyme discovery can be used to revive progesterone therapy to delay or stop preterm birth.
MODCAST
Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.
